Catalysts
Catalysts — What Can Move the Stock
Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.
The next six months hinge on a single binary debate that splits into two dated events: Q2 2026 results on July 21 (does the Q1 risk-cost step-up stick) and the PTSB Scheme Meeting / EGM later this summer (does minority dissent force a price sweetener even though the Irish State's 57.5% stake is committed). Everything else — four ECB monetary-policy decisions, two analyst conferences, Q3 2026 in October, the regulatory clock toward a Q4 2026 / Q1 2027 PTSB closing — is supporting cast for those two prints. The calendar is moderate, not thin: dates are confirmed, but the high-impact items cluster, leaving June and most of August as drift-on-tape windows. NIM is the unspoken third event in the room — the ECB held at a 2.00% deposit / 2.15% main refi rate in April with markets now flirting with hikes (a bear-thesis-busting reversal of the rate-rolling-over narrative), and Q2 will be the first quarterly print to mark whether 3.29% NIM survives.
Catalyst Setup
Hard-Dated Events (next 6m)
High-Impact Catalysts
Days to Next Hard Date
Signal Quality (1-5)
Single highest-impact event in the window: Q2 2026 results on July 21, 2026. After Q1's first clean miss since 2023 — net profit $267M vs $282M consensus, provisions running $9M hot — Q2 is the first quarterly print where the bear's "risk-cost step-up at $304M run-rate, NIM rolling over" thesis can be confirmed or invalidated. Note the ECB monetary-policy decision lands two days later (July 23), so any rate-trajectory commentary on the call will be marked against the ECB statement immediately.
Ranked Catalyst Timeline
The ranking favours the events that resolve the active bull/bear tension over events that merely add information. Q2 results are #1 because they take the bear's central piece of evidence — the Q1 first-since-2023 miss with provisions running hot — and either confirm a trend or revert to a one-quarter outlier. The PTSB shareholder vote sits at #2 because it gates the regulatory clock; the vote itself is not in doubt (Irish State at 57.5% is committed), but a price sweetener would mechanically rerate the IRR math the bull case relies on. ECB decisions are deliberately #5: the rate path matters but each meeting is a small marginal data point against a NIM that has compounded for three years.
Impact Matrix
Two events on this matrix actually resolve the debate rather than adding noise: Q2 results and the PTSB regulatory approval pace. Q2 is the higher-information event because it is dated and the variant-perception gap (consensus at $282M vs the bear's $269M case) is well-defined. The PTSB approval pace is the lower-information but higher-payoff event: a clean approval in Q4 2026 makes the bull's "compounder pull-forward" math work, while a CCPC Phase 2 or CBI capital condition turns it into a 2027 story.
Next 90 Days
The 90-day calendar is moderate-busy at the back end and quiet at the front. May and most of June are tape-driven; the action concentrates in three events between July 7 and July 23, all with marketable consequences for the same thesis. The PTSB Scheme Document despatch could land inside the window (precise date set when filed with the Irish High Court) and would meaningfully tighten the timeline on the shareholder vote — that is the single soft-window event a PM should keep loaded into the screen.
What Would Change the View
Three observable signals over the next six months would force the bull/bear debate to update. First, the Q2 2026 risk-cost line: anything sustained above $82M (annualized $328M+) confirms the bear thesis on consumer-book normalization and forces estimate cuts the multiple has not priced; a clean $64-70M reverts the print to noise and reseats the 2.91× P/TBV. Second, the PTSB shareholder-vote outcome relative to a sweetener: a clean pass at $3.48 with the Irish State carrying the vote validates the M&A-as-strategy thesis (Bull point #2) and starts the regulatory clock; a forced bump or a vote that requires the Irish State to make up for minority dissent kills the deal-IRR framing the rerating relies on. Third, the ECB rate path: markets are now flirting with hikes after the April hold, which would reverse the bear's "rate cycle rolling over" narrative and effectively rebuild the NIM-tailwind that delivered the 2023-2025 RoTCE step-change. These three signals — risk costs, the PTSB vote, and the ECB rate path — together are the only events between now and Q3 results that can make the multiple do something it has not been able to do for twelve months: either rerate to AIB-like 1.7× or rerate up to a 3.5× pull-forward case.